Awards as PI
Program Type | Institution | Grant Title | Award Value |
---|---|---|---|
Quest - Discovery Stage Research Projects | ViaCyte, Inc. | Preclinical development of an immune evasive islet cell replacement therapy for type 1 diabetes | $1,470,987 |
Total: $1,470,987.00 |